R9U2 Stock Overview
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Green Thumb Industries Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$9.00 |
| 52 Week High | CA$14.40 |
| 52 Week Low | CA$7.40 |
| Beta | 1.45 |
| 11 Month Change | -10.89% |
| 3 Month Change | -4.66% |
| 1 Year Change | -1.80% |
| 33 Year Change | -56.86% |
| 5 Year Change | 7.14% |
| Change since IPO | 56,150.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| R9U2 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 2.3% | -7.0% | -0.4% |
| 1Y | -1.8% | -21.6% | 7.1% |
Return vs Industry: R9U2 exceeded the German Pharmaceuticals industry which returned -21.6% over the past year.
Return vs Market: R9U2 underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| R9U2 volatility | |
|---|---|
| R9U2 Average Weekly Movement | 9.8% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: R9U2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: R9U2's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 4,800 | Ben Kovler | www.gtigrows.com |
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.
Green Thumb Industries Inc. Fundamentals Summary
| R9U2 fundamental statistics | |
|---|---|
| Market cap | €2.18b |
| Earnings (TTM) | €60.69m |
| Revenue (TTM) | €1.07b |
34.6x
P/E Ratio2.0x
P/S RatioIs R9U2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R9U2 income statement (TTM) | |
|---|---|
| Revenue | US$1.12b |
| Cost of Revenue | US$535.32m |
| Gross Profit | US$585.73m |
| Other Expenses | US$522.11m |
| Earnings | US$63.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 52.25% |
| Net Profit Margin | 5.68% |
| Debt/Equity Ratio | 14.4% |
How did R9U2 perform over the long term?
See historical performance and comparison